NEW YORK, November 12, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced positive results from the initial cohort of the Phase IIb trial evaluating the efficacy and safety of its lead oral insulin candidate, ORMD-0801, which has th

MIAMI, Nov. 12, 2019 /PRNewswire/ -- ArisGlobal, the visionary technology provider of automated solutions for the life sciences industry, is proud to announce that ten life sciences companies have switched to its industry-leading LifeSphere® MultiVigilance

REHOVOT, Israel, Nov. 12, 2019 /PRNewswire/ -- Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today positive preliminary results from recently completed animal studies in its immuno-oncology program, wherein anti-tumor activity was tested

SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Neurovalens, a global HealthTech company focused on developing innovative neuroscience-powered products to improve lives, today launches its Modius SLEEP campaign on Indiegogo. The device follows the success of the Company's first headset,

INDIANAPOLIS, Nov. 12, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the 52-week results from the Phase 3b/4 SPIRIT-Head-to-Head (H2H) study of Taltz® (ixekizumab) versus Humira® (adalimumab) in biologic-naïve patients with active psoriatic arthritis (PsA). The results are bein

MEMPHIS, Tenn., Nov. 12, 2019 /PRNewswire/ -- West Cancer Center is committed to closing the gap in cancer care disparity in the Mid-South. Since 1979, West has spent over $82 Million on uninsured and underinsured patients in an area where Memphis was ranked #1 in breast care mortality disparity.  Shelby

HOUSTON, Nov. 12, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced its financial results for the third quarter ended September 30, 2019. Additionally

WASHINGTON, Nov. 12, 2019 /PRNewswire/ -- Thousands of advocates for children's health will gather Thursday at the Vaccine Injury Epidemic (VIE) Event on the National Mall to

YORK, England, Nov. 12, 2019 /PRNewswire/ -- A select group of farmers have pioneered production of Ahiflower — the best plant-derived source of healthy omegas in over 50 years. Omegas are essential for every cell in our bodies — especially joints, brain, heart, and immune system. Humans must obtain them from their di

MINNEAPOLIS, Nov. 12, 2019 /PRNewswire/ -- Representatives from Revel, the nation's leading health action platform, announced today they have broken new ground with a tool that helps identify and prioritize the most effective social determinants of health (SDoH) programs. Revel's Social Determinants of Health Assessment is an advanced, multi-channel outreach program